hVIVO PLC
LSE:HVO
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
18
30.6
|
Price Target |
|
We'll email you a reminder when the closing price reaches GBX.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one HVO stock under the Base Case scenario is 26.83 GBX. Compared to the current market price of 22 GBX, hVIVO PLC is Undervalued by 18%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
hVIVO PLC
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for HVO cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Economic Moat
hVIVO PLC
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
hVIVO PLC
Balance Sheet Decomposition
hVIVO PLC
Current Assets | 57.8m |
Cash & Short-Term Investments | 37.1m |
Receivables | 20.4m |
Other Current Assets | 340k |
Non-Current Assets | 29.9m |
PP&E | 20.2m |
Intangibles | 5.7m |
Other Non-Current Assets | 4m |
Current Liabilities | 36m |
Accounts Payable | 34.1m |
Other Current Liabilities | 1.9m |
Non-Current Liabilities | 13.3m |
Long-Term Debt | 11.7m |
Other Non-Current Liabilities | 1.6m |
Earnings Waterfall
hVIVO PLC
Revenue
|
64.4m
GBP
|
Operating Expenses
|
-51m
GBP
|
Operating Income
|
13.3m
GBP
|
Other Expenses
|
4.1m
GBP
|
Net Income
|
17.4m
GBP
|
Free Cash Flow Analysis
hVIVO PLC
GBP | |
Free Cash Flow | GBP |
HVO Profitability Score
Profitability Due Diligence
hVIVO PLC's profitability score is 73/100. The higher the profitability score, the more profitable the company is.
Score
hVIVO PLC's profitability score is 73/100. The higher the profitability score, the more profitable the company is.
HVO Solvency Score
Solvency Due Diligence
hVIVO PLC's solvency score is 68/100. The higher the solvency score, the more solvent the company is.
Score
hVIVO PLC's solvency score is 68/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
HVO Price Targets Summary
hVIVO PLC
According to Wall Street analysts, the average 1-year price target for HVO is 37.06 GBX with a low forecast of 27.27 GBX and a high forecast of 44.1 GBX.
Dividends
Current shareholder yield for HVO is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
hVIVO PLC provides pharmaceutical development services. The firm is engaged in testing infectious and respiratory disease vaccines and therapeutics using human challenge clinical trials. The company provides end-to-end early clinical development services to its client base, which includes global biopharma companies. The company offers a portfolio of approximately 10+ human challenge models to test a range of infectious and respiratory disease products, challenge agent manufacturing, specialist drug development, and clinical consultancy services via its Venn Life Sciences brand, and a lab offering via its hLAB brand, which includes virology, immunology biomarker and molecular testing. The company offers additional clinical field trial services, such as patient recruitment and clinical trial site services. The company runs challenge studies in from its Whitechapel quarantine clinic, and its QMB clinic with its specialized on-site virology and immunology laboratory.
Contact
IPO
Employees
Officers
The intrinsic value of one HVO stock under the Base Case scenario is 26.83 GBX.
Compared to the current market price of 22 GBX, hVIVO PLC is Undervalued by 18%.